(19)
(11) EP 4 816 402 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24827996.0

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2875; A61K 2039/505; C07K 2317/565; C07K 2317/56; A61K 2039/54; A61K 2039/545
(86) International application number:
PCT/US2024/057894
(87) International publication number:
WO 2025/117849 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 28.11.2023 US 202363603591 P
07.05.2024 US 202463643866 P

(71) Applicant: Eledon Pharmaceuticals, Inc.
Irvine, California 92612 (US)

(72) Inventor:
  • PERRIN, Steven N.
    Newbury, Massachusetts 01951 (US)

(74) Representative: Hancock, Susan Marie et al
Kilburn & Strode LLP Lacon London 84 Theobalds Road
London WC1X 8NL
London WC1X 8NL (GB)

   


(54) METHODS AND COMPOSITIONS FOR PREVENTION OF TRANSPLANT REJECTION